COMMUNIQUÉS West-GlobeNewswire

VBI Vaccines Announces Pricing of $37.5 Million Public Offering
13/12/2018
CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
Aptevo Therapeutics Doses First Patient in Phase 1/1b Clinical Trial of Lead Next-Generation Bispecific Antibody APVO436
13/12/2018
Preclinical Data for APVO436 Show Potential Best-in-Class Attributes with Potent T-Cell Directed Tumor Killing and Reduced Cytokine Production Compared to a Competitor Construct Phase 1/1b Clinical Trial to Evaluate [...]
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline
13/12/2018
LONG ISLAND, NY, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Deep Blue Med Spa, overseen by the plastic surgeons at Long Island Plastic Surgical Group , is pleased to announce the addition of Profound, a unique microneedling [...]
Symphony Health Announces Availability of 340B Drug Discount Program Data
13/12/2018
Program data provides comprehensive measurement of large-scale 340B transaction activity across outlets BLUE BELL, Pa., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Symphony Health , a PRA Health Sciences company and a leading [...]
Agritek Holdings, Inc. Applauds Passing Of 2018 US Hemp Farm Bill With Company Poised To Monetize Colorado Assets Through Approved Hemp License And Production Partners
13/12/2018
LOS ANGELES, CA, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector in the [...]
Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome
13/12/2018
MENLO PARK, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that the United States Patent and Trademark Office has given notice that it will allow a patent [...]
Blockchain Technology Offers a Solution to Cannabis Quality Control -- CFN Media
13/12/2018
SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Yield10 Bioscience Names Sherri M. Brown, Ph.D., Former Monsanto Executive, as Special Commercial and Technical Advisor
13/12/2018
WOBURN, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, today [...]
Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production -- CFN Media
13/12/2018
SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
13/12/2018
MELBOURNE, Australia, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that the Australian [...]
CLS Holdings USA Closes approximately $12 Million Private Placement of Convertible Debentures
13/12/2018
LAS VEGAS, Dec. 13, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]
XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study
13/12/2018
Biomarkers Predict Significantly Higher Rates of Treatment Response to Bermekimab in Advanced Cancer Patients AUSTIN, Texas, Dec. 13, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the publication [...]
Canntab Partners with Leading Surgeon to Conduct Pain Management Trial -- CFN Media
13/12/2018
SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Sport Endurance Appoints Michael Young to Board of Directors
13/12/2018
JERSEY CITY, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTCQB: SENZ) (the “Company”) is pleased to announce the appointment of Michael Young as Chairman of the Board of Directors. Mr. Young’s [...]
Inspire’s Health Profiles Identifies the Insights of Patients to Unlock Research Gaps
13/12/2018
Company invites new global academic collaborations to accelerate clinical research ARLINGTON, Va., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network for patients and caregivers, is [...]
Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California
13/12/2018
New facility expected to create more than 100 new jobs, supporting extensive gene therapy pipeline Enhances Orchard’s capacity to develop and deliver lentiviral vector and gene-corrected hematopoetic stem cells for wide [...]
HEXO Corp reports $6.7 million in gross revenue for the first quarter of new fiscal year
13/12/2018
Sales of $5.2 million for adult-use cannabis during the first two weeks of legalization in Canada Creation of Truss, a partnership with Molson Coors Canada in support of the Company’s objective to partner with Fortune [...]
HEXO Corp déclare des revenus bruts de 6,7 millions de dollars pour le premier trimestre du nouvel exercice
13/12/2018
Ventes de 5,2 millions de dollars de cannabis destiné au marché adulte au cours des deux premières semaines suivant la légalisation au Canada Création de Truss, un partenariat avec Molson Coors Canada à l’appui de l’ [...]
Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion
13/12/2018
GAITHERSBURG, Md., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced updates to its clinical programs and plans to further expand its pipeline [...]

Pages